Edition:
United States

Yasmeen Abutaleb

U.S. health agency finalizes conscience and religious freedom rule

May 02 2019

WASHINGTON The U.S. Department of Health and Human Services on Thursday released a final rule allowing doctors, nurses and other health workers to opt out of procedures such as abortions and sterilizations which violate their personal or religious beliefs.

U.S. health agency finalizes conscience and religious freedom rule

May 02 2019

WASHINGTON The U.S. Department of Health and Human Services on Thursday released a final rule allowing doctors, nurses and other health workers to opt out of procedures such as abortions and sterilizations which violate their personal or religious beliefs.

Top Democrats leave open option of Trump impeachment after Mueller report

Apr 21 2019

WASHINGTON Top congressional Democrats left the door open on Sunday to the impeachment of U.S. President Donald Trump, but said they would first need to complete their own investigations into whether he obstructed justice in Special Counsel Robert Mueller's Russia probe. | Video

U.S. FDA chief tough on e-cigarettes steps down abruptly

Mar 06 2019

WASHINGTON U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

CORRECTED-UPDATE 4-U.S. FDA chief tough on e-cigs steps down in surprise resignation

Mar 05 2019

WASHINGTON, March 5 U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug

Feb 28 2019

U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.

U.S. House Democrats introduce sweeping 'Medicare for All' bill

Feb 28 2019

WASHINGTON Democrats in the U.S. House of Representatives unveiled an ambitious proposal on Tuesday to move all Americans into the government's Medicare health insurance program, tapping into public frustration over the rising cost of healthcare that has become a key issue for the party as it seeks to gain control of Congress and the White House in 2020. | Video

U.S. Senator Sanders urges FDA to allow older versions of $375K drug

Feb 28 2019

Feb 28 U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.

U.S. senators tell drug company executives pricing is 'morally repugnant'

Feb 26 2019

WASHINGTON/NEW YORK U.S. senators called drug pricing practices "morally repugnant" and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines.

Drug company executives to testify before U.S. Senate

Feb 26 2019

WASHINGTON/NEW YORK Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a sharp escalation in lawmakers' promises to address high medicine costs.

World News